Literature DB >> 28461455

Loss of Smooth Muscle α-Actin Leads to NF-κB-Dependent Increased Sensitivity to Angiotensin II in Smooth Muscle Cells and Aortic Enlargement.

Jiyuan Chen1, Andrew Peters1, Christina L Papke1, Carlos Villamizar1, Lea-Jeanne Ringuette1, Jiumei Cao1, Shanzhi Wang1, Shuangtao Ma1, Limin Gong1, Katerina L Byanova1, Jian Xiong1, Michael X Zhu1, Rosalinda Madonna1, Patrick Kee1, Yong-Jian Geng1, Allan R Brasier1, Elaine C Davis1, Siddharth Prakash1, Callie S Kwartler1, Dianna M Milewicz2.   

Abstract

RATIONALE: Mutations in ACTA2, encoding the smooth muscle isoform of α-actin, cause thoracic aortic aneurysms, acute aortic dissections, and occlusive vascular diseases.
OBJECTIVE: We sought to identify the mechanism by which loss of smooth muscle α-actin causes aortic disease. METHODS AND
RESULTS: Acta2-/- mice have an increased number of elastic lamellae in the ascending aorta and progressive aortic root dilation as assessed by echocardiography that can be attenuated by treatment with losartan, an angiotensin II (AngII) type 1 receptor blocker. AngII levels are not increased in Acta2-/- aortas or kidneys. Aortic tissue and explanted smooth muscle cells from Acta2-/- aortas show increased production of reactive oxygen species and increased basal nuclear factor κB signaling, leading to an increase in the expression of the AngII receptor type I a and activation of signaling at 100-fold lower levels of AngII in the mutant compared with wild-type cells. Furthermore, disruption of smooth muscle α-actin filaments in wild-type smooth muscle cells by various mechanisms activates nuclear factor κB signaling and increases expression of AngII receptor type I a.
CONCLUSIONS: These findings reveal that disruption of smooth muscle α-actin filaments in smooth muscle cells increases reactive oxygen species levels, activates nuclear factor κB signaling, and increases AngII receptor type I a expression, thus potentiating AngII signaling in vascular smooth muscle cells without an increase in the exogenous levels of AngII.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  angiotensins; aorta; losartan; mutation; reactive oxygen species

Mesh:

Substances:

Year:  2017        PMID: 28461455      PMCID: PMC5518614          DOI: 10.1161/CIRCRESAHA.117.310563

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  38 in total

1.  Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells.

Authors:  Adrian Manea; Laurentia I Tanase; Monica Raicu; Maya Simionescu
Journal:  Biochem Biophys Res Commun       Date:  2010-05-10       Impact factor: 3.575

2.  Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.

Authors:  Daniel Paris; David Beaulieu-Abdelahad; Corbin Bachmeier; Jon Reed; Ghania Ait-Ghezala; Alex Bishop; Jin Chao; Venkat Mathura; Fiona Crawford; Michael Mullan
Journal:  Eur J Pharmacol       Date:  2011-09-19       Impact factor: 4.432

Review 3.  Measurement of reactive oxygen species in cardiovascular studies.

Authors:  Sergey Dikalov; Kathy K Griendling; David G Harrison
Journal:  Hypertension       Date:  2007-02-12       Impact factor: 10.190

4.  Poldip2 controls vascular smooth muscle cell migration by regulating focal adhesion turnover and force polarization.

Authors:  Srinivasa Raju Datla; Daniel J McGrail; Sasa Vukelic; Lauren P Huff; Alicia N Lyle; Lily Pounkova; Minyoung Lee; Bonnie Seidel-Rogol; Mazen K Khalil; Lula L Hilenski; Lance S Terada; Michelle R Dawson; Bernard Lassègue; Kathy K Griendling
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-25       Impact factor: 4.733

5.  Vascular disease-causing mutation R258C in ACTA2 disrupts actin dynamics and interaction with myosin.

Authors:  Hailong Lu; Patricia M Fagnant; Carol S Bookwalter; Peteranne Joel; Kathleen M Trybus
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-07       Impact factor: 11.205

6.  A lamellar unit of aortic medial structure and function in mammals.

Authors:  H Wolinsky; S Glagov
Journal:  Circ Res       Date:  1967-01       Impact factor: 17.367

7.  RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs.

Authors:  Ruwen Cui; Brian Tieu; Adrian Recinos; Ronald G Tilton; Allan R Brasier
Journal:  Circ Res       Date:  2006-09-07       Impact factor: 17.367

8.  Disruption of SM22 promotes inflammation after artery injury via nuclear factor kappaB activation.

Authors:  Jianbin Shen; Maozhou Yang; Donghong Ju; Hong Jiang; Jian-Pu Zheng; Zhonghui Xu; Li Li
Journal:  Circ Res       Date:  2010-03-11       Impact factor: 17.367

9.  Novel arterial pathology in mice and humans hemizygous for elastin.

Authors:  D Y Li; G Faury; D G Taylor; E C Davis; W A Boyle; R P Mecham; P Stenzel; B Boak; M T Keating
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

10.  Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.

Authors:  Jennifer P Habashi; Jefferson J Doyle; Tammy M Holm; Hamza Aziz; Florian Schoenhoff; Djahida Bedja; YiChun Chen; Alexandra N Modiri; Daniel P Judge; Harry C Dietz
Journal:  Science       Date:  2011-04-15       Impact factor: 47.728

View more
  23 in total

Review 1.  Genetics of Thoracic and Abdominal Aortic Diseases.

Authors:  Amélie Pinard; Gregory T Jones; Dianna M Milewicz
Journal:  Circ Res       Date:  2019-02-15       Impact factor: 17.367

Review 2.  Therapeutics Targeting Drivers of Thoracic Aortic Aneurysms and Acute Aortic Dissections: Insights from Predisposing Genes and Mouse Models.

Authors:  Dianna M Milewicz; Siddharth K Prakash; Francesco Ramirez
Journal:  Annu Rev Med       Date:  2017-01-14       Impact factor: 13.739

Review 3.  Therapies for Thoracic Aortic Aneurysms and Acute Aortic Dissections.

Authors:  Dianna M Milewicz; Francesco Ramirez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

Review 4.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 5.  Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target.

Authors:  Abhijit Chakraborty; Yang Li; Chen Zhang; Yanming Li; Scott A LeMaire; Ying H Shen
Journal:  J Mol Cell Cardiol       Date:  2021-09-28       Impact factor: 5.000

6.  Controlled Comparison of Simulated Hemodynamics Across Tricuspid and Bicuspid Aortic Valves.

Authors:  Alexander D Kaiser; Rohan Shad; Nicole Schiavone; William Hiesinger; Alison L Marsden
Journal:  Ann Biomed Eng       Date:  2022-06-24       Impact factor: 4.219

7.  Drebrin regulates angiotensin II-induced aortic remodelling.

Authors:  Lisheng Zhang; Jiao-Hui Wu; Tai-Qin Huang; Igor Nepliouev; Leigh Brian; Zhushan Zhang; Virginia Wertman; Nathan P Rudemiller; Timothy J McMahon; Sudha K Shenoy; Francis J Miller; Steven D Crowley; Neil J Freedman; Jonathan A Stiber
Journal:  Cardiovasc Res       Date:  2018-11-01       Impact factor: 10.787

8.  Variants of Unknown Significance in Genes Associated with Heritable Thoracic Aortic Disease Can Be Low Penetrant "Risk Variants".

Authors:  Callie S Kwartler; Limin Gong; Jiyuan Chen; Shanzhi Wang; Richard Kulmacz; Xue-Yan Duan; Alexandra Janda; Jian Huang; Kristine E Kamm; James T Stull; Dongchuan Guo; Dianna M Milewicz
Journal:  Am J Hum Genet       Date:  2018-06-28       Impact factor: 11.025

Review 9.  Marfan syndrome.

Authors:  Dianna M Milewicz; Alan C Braverman; Julie De Backer; Shaine A Morris; Catherine Boileau; Irene H Maumenee; Guillaume Jondeau; Arturo Evangelista; Reed E Pyeritz
Journal:  Nat Rev Dis Primers       Date:  2021-09-02       Impact factor: 65.038

Review 10.  A promising field: regulating imbalance of EndMT in cardiovascular diseases.

Authors:  Kun Zhou; Kai-Jiang Tian; Bin-Jie Yan; Dan-Dan Gui; Wen Luo; Zhong Ren; Dang-Heng Wei; Lu-Shan Liu; Zhi-Sheng Jiang
Journal:  Cell Cycle       Date:  2021-07-16       Impact factor: 5.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.